Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Double Cord Blood Transplant Study
- Status
- COMPLETED
- Phase
- PHASE2
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Stem Cell Transplant for Hematologic Diseases
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Gelonin Purging of Autologous Stem Cells for Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients
- Status
- TERMINATED
- Phase
- PHASE1
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies
- Status
- TERMINATED
- Phase
- PHASE2
Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Campath in Nonmyeloablative Transplantation
- Status
- COMPLETED
- Phase
- NA